I Ales
Overview
Explore the profile of I Ales including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
35
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benavides M, Alcaide-Garcia J, Torres E, Gil-Calle S, Sevilla I, Wolman R, et al.
ESMO Open
. 2022 May;
7(3):100481.
PMID: 35525184
Background: Comprehensive biomarker testing is essential in selecting optimal treatment for patients with metastatic colorectal cancer (mCRC); however, incomplete genotyping is widespread, with most patients not receiving testing for all...
2.
Alvarez R, Carrato A, Adeva J, Ales I, Prados S, Valladares M, et al.
Eur J Cancer
. 2018 Mar;
94:26-36.
PMID: 29505968
Development of hyperbilirubinaemia is common in patients with advanced pancreatic adenocarcinoma, both at diagnosis as well throughout disease evolution. For this reason, hyperbilirubinaemia determines chemotherapy treatment selection, and therefore it...
3.
Alvarez R, Ales I, Diaz R, de Paredes B, Hidalgo M
Clin Transl Oncol
. 2017 Jun;
19(10):1193-1198.
PMID: 28612203
Nowadays and given the improvement in response rate with the new schemes of treatment with chemotherapy, the interest in neoadjuvant treatment for pancreatic ductal adenocarcinoma, allowing the early application of...
4.
Hidalgo M, Alvarez R, Gallego J, Guillen-Ponce C, Laquente B, Macarulla T, et al.
Clin Transl Oncol
. 2016 Dec;
19(6):667-681.
PMID: 27995549
The management of patients with pancreatic cancer has advanced over the last few years. We convey a multidisciplinary group of experts in an attempt to stablish practical guidelines for the...
5.
Benavides M, Abad A, Ales I, Carrato A, Diaz Rubio E, Gallego J, et al.
Clin Transl Oncol
. 2014 Apr;
16(10):865-78.
PMID: 24728654
Exocrine pancreatic cancer (PC) is a very aggressive and heterogeneous tumor with several cellular signaling pathways implicated in its pathogenesis and maintenance. Several risk factors increase the risk of developing...
6.
Cobo M, Delgado R, Gil S, Herruzo I, Baena V, Carabante F, et al.
Clin Transl Oncol
. 2006 Dec;
8(12):903-11.
PMID: 17169764
Purpose: Organ preservation has been investigated in patients (p) with infiltrating transitional cell carcinoma (TCC) of the bladder over the past decade as an alternative to radical cystectomy. This is...